Impact Factor
3.28
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
2.69
759 total citations
h5-index
31
h5 depth signal
Cited share
61.4%
199 of 324
Total citations
759
Citation footprint
Metric signal
1.44
External metric anchor
Self-citation
0.1%
1 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
803
United Kingdom
433
South Africa
333
India
234
France
201
Citing Fields of Research
Mycobacterial Diseases
1,896
Healthcare Policy
127
Allergies
122
Respiratory Support
75
Lung Cancer
64
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
4,008
Articles tracked across the journal lifetime
Indexed publication set
324
199 cited publications
Last 12 months
114
11.4 publications/month
Open access share
0.0%
0 OA publications in the last year
Leading citing country
United States
803 citing publications
Leading citing field
Mycobacterial Diseases
1,896 citing publications
Latest tracked publication
30 September 2026
10 recent records available
Coverage & Indexing History
v1n1,Feb. 1997-
v1n1,Feb. 1997-
Active Coverage
Active Coverage
Research Focus & Classification
Indexed Subjects
Mycobacterial Diseases
Issuing & Sponsoring Bodies
Contributor
International Union against Tuberculosis and Lung Disease
Contributor
World Conference on Lung Health of the International Union Against Tuberculosis and Lung Disease
Broad Categories
Pulmonary Medicine
Mycobacterial Diseases
MeSH Descriptors
Lung Diseases
Tuberculosis
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.5588/ijtld.26.0442
Open DOI
Results of the FAST-TB end-users’ survey align with priority research questions on new TB treatment regimens
BACKGROUNDRapid adoption and scale-up of new anti-TB regimens requires evidence on efficacy and safety, but also on end-user preferences, implementation barriers, regulatory hurdles, and local conditions. The aim of this study is to desc...
02
DOI 10.5588/ijtld.26.0348
Open DOI
Inequities in access to TB care: insights from a community, rights, and gender assessment
03
DOI 10.5588/ijtld.26.0308
Open DOI
Modelling the health impact of TB active-case-finding interventions in Papua New Guinea
04
DOI 10.5588/ijtld.26.0234
Open DOI
Chest radiography may underestimate TB during contact investigation in a school cluster
05
DOI 10.5588/ijtld.26.0206
Open DOI
Diabetes prevalence and factors associated with newly detected diabetes in elderly TB patients
BACKGROUNDTB and diabetes mellitus (DM) frequently coexist, particularly in low- and middle-income countries. Evidence on their coexistence among the elderly in Bangladesh is limited. This study assessed prevalence of diabetes and associ...
06
07
DOI 10.5588/ijtld.26.0111
Open DOI
Unmasking isoniazid resistance in rifampicin-susceptible TB: a national multicentre study using Xpert MTB/XDR
BACKGROUNDTB remains a major global health threat, worsened by drug resistance. Hr-TB (isoniazid resistance) in rifampicin-susceptible cases compromises outcomes. This study used Xpert MTB/XDR to determine Hr-TB prevalence and associated...
08
DOI 10.5588/ijtld.26.0053
Open DOI
Improving childhood TB case notification through intensified clinical services
BACKGROUNDChildhood TB is a major cause of morbidity and mortality among children under 15, with diagnosis challenged by non-specific symptoms and paucibacillary disease. This study analysed the impact of intensified clinical interventio...
09
DOI 10.5588/ijtld.26.0038
Open DOI
Factors associated with primary rifampicin-resistant/multidrug-resistant TB: a case-control study
BACKGROUNDMultidrug-resistant TB (MDR-TB) threatens TB control in Bhutan. According to the 2017 national Drug Resistance Surveillance report of the Royal Centre for Disease Control, 13.7% of new pulmonary TB cases had rifampicin resistan...
10
DOI 10.5588/ijtld.26.0298
Open DOI
Overall sensitivity of tongue swab Xpert MTB/RIF Ultra testing for TB
Bibliographical & Catalog Notes
Title from cover.
Some supplements on CD-ROM.
Print issues ceased with 2023.
Some issues contain the abstracts from the World Conference on Lung Health of the International Union Against Tuberculosis and Lung Disease, 35th-.
Also issued online.
Vol. 1, no. 1 (FEB 1997)19980130 Notice published Printed on acid-free paper that meets the full ANSI standard for Permanent Paper